# A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.

> **NCT00424697** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 26 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** placebo
- **DRUG:** lorazepam
- **DRUG:** GW876008

## Key facts

- **NCT ID:** NCT00424697
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424697, "A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00424697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*